fluoxetine has been researched along with Seizures in 84 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The AFFINITY trial (Assessment of Fluoxetine in Stroke Recovery) reported that oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and seizures." | 9.41 | Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration. ( Almeida, OP; Anderson, CS; Billot, L; Dennis, MS; Etherton-Beer, C; Flicker, L; Ford, AH; Gommans, J; Hackett, ML; Hankey, GJ; Jan, S; Lundström, E; Lung, T; Mead, GE; Sunnerhagen, KS; Thang-Nguyen, H; Yi, Q, 2021) |
| "Serotonin and fluoxetine, but not sumatriptan, alleviated PTZ-induced seizures by prolonging onset times of myoclonic-jerk and generalized tonic-clonic seizures." | 8.12 | Endogenous and exogenous serotonin, but not sumatriptan, ameliorate seizures and neuroinflammation in the pentylenetetrazole-induced seizure model in rats. ( Kilinc, E; Kılınc, YB; Torun, IE, 2022) |
| " The aim of this study was to investigate whether anxiety or depression-like behavior can be found in rat strains with different susceptibility to audiogenic seizures (AS) and whether chronic fluoxetine treatment affects this co-morbidity." | 7.85 | Genetic background contributes to the co-morbidity of anxiety and depression with audiogenic seizure propensity and responses to fluoxetine treatment. ( Fedotova, IB; Kostina, ZA; Nikolaev, GM; Perepelkina, OV; Poletaeva, II; Sarkisova, KY; Surina, NM, 2017) |
| "The effects of tianeptine and fluoxetine on pentylenetetrazole (PTZ)-induced seizures in rats were investigated." | 7.73 | Investigation of the effects of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats. ( Ceyhan, M; Kayir, H; Uzbay, IT, 2005) |
| "This work was designed to study the influence of drugs during seizures and status epilepticus (SE) induced by pilocarpine and mortality in adult rats." | 7.73 | Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus. ( Fonteles, MM; Freitas, RM; Sousa, FC; Viana, GS, 2006) |
| "The aim of this study was to examine the effects of acute fluoxetine treatment on pentylenetetrazol-induced convulsions in order to shape a model of seizures associated with treatment with antidepressants in rats." | 7.73 | The effect of fluoxetine in a model of chemically induced seizures--behavioral and immunocytochemical study. ( Lehner, M; Maciejak, P; Płaźnik, A; Skórzewska, A; Taracha, E; Wisłowska, A; Zienowicz, M, 2005) |
| " The present study was undertaken to examine the role of ALLO in the anticonvulsant action of fluoxetine against pentylenetetrazole (PTZ)-induced seizures in mice." | 7.72 | Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice. ( Chopde, CT; Hirani, K; Mittal, N; Ugale, RR, 2004) |
| " The present study assessed the effects of concomitant administration of fluoxetine and a 5-HT1A receptor antagonist, pindolol, on focal hippocampal (HIP) seizures elicited by electrical stimulation in rats." | 7.70 | Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats. ( Hirao, N; Koshino, Y; Nakamura, M; Shiraishi, J; Wada, Y, 1999) |
| "This study assessed the effects of acute as well as long-term administration of fluoxetine, a selective serotonin (5-HT) reuptake inhibitor with anti-depressant properties, on hippocampal (HIP) seizures elicited by electrical stimulation in rats." | 7.69 | Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. ( Hasegawa, H; Nakamura, M; Shiraishi, J; Wada, Y, 1995) |
| "Fluoxetine, an antidepressant and inhibitor of serotonin reuptake, was evaluated as an anticonvulsant in genetically epilepsy-prone rats (GEPRs) because seizure predisposition in GEPRs is partially dependent on deficits in brain serotonin." | 7.68 | Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. ( Burger, RL; Dailey, JW; Jobe, PC; Mishra, PK; Yan, QS, 1992) |
| "The effects of fluoxetine [an inhibitor of 5-hydroxytryptamine (5-HT) reuptake] on electrically-induced spinal cord seizures were determined by monitoring alterations in the total duration of seizure, as well as the durations of tonic flexion and extension." | 7.66 | Effects of fluoxetine on electrically-induced spinal cord seizures in rats. ( Jobe, PC; Ray, TB; Woods, TW, 1980) |
| "Fluoxetine is a selective serotonin reuptake inhibitor that is less frequently associated with severe toxicity in acute overdose compared with other psychotropic medications." | 6.44 | Generalized seizures after acute fluoxetine overdose in four adolescents. ( Kolbeck, MK; Nacca, N; Schult, RF, 2024) |
| "Fluoxetine is a relatively new antidepressant, reported to have minimal side-effects." | 6.38 | Seizures associated with fluoxetine therapy. ( Prasher, VP, 1993) |
| "Complete freedom from seizures with cyanosis was reached in 3 (21 %) patients, and only one patient with early-onset epilepsy related to an FHF1 mutation was completely seizure-free." | 5.62 | Fluoxetine as adjunctive therapy in pediatric patients with refractory epilepsy: A retrospective analysis. ( Desnous, B; Milh, M; Neveu, J; Villeneuve, N, 2021) |
| "He had a generalised tonic/clonic seizure at 6 hours postingestion." | 5.48 | Fluoxetine overdose in a teenager resulting in serotonin syndrome, seizure and delayed onset rhabdomyolysis. ( Lee-Kelland, R; Mappa, P; Zehra, S, 2018) |
| "The AFFINITY trial (Assessment of Fluoxetine in Stroke Recovery) reported that oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and seizures." | 5.41 | Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration. ( Almeida, OP; Anderson, CS; Billot, L; Dennis, MS; Etherton-Beer, C; Flicker, L; Ford, AH; Gommans, J; Hackett, ML; Hankey, GJ; Jan, S; Lundström, E; Lung, T; Mead, GE; Sunnerhagen, KS; Thang-Nguyen, H; Yi, Q, 2021) |
| "Down syndrome is caused by triplication of chromosome 21 and is associated with neurocognitive phenotypes ranging from severe intellectual disability to various patterns of more selective neuropsychological deficits, including memory impairments." | 5.38 | Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome. ( Ehninger, D; Heinen, M; Hettich, MM; Paesler, K; Ryan, DP; Schnell, S, 2012) |
| "Serotonin and fluoxetine, but not sumatriptan, alleviated PTZ-induced seizures by prolonging onset times of myoclonic-jerk and generalized tonic-clonic seizures." | 4.12 | Endogenous and exogenous serotonin, but not sumatriptan, ameliorate seizures and neuroinflammation in the pentylenetetrazole-induced seizure model in rats. ( Kilinc, E; Kılınc, YB; Torun, IE, 2022) |
| " The aim of this study was to investigate whether anxiety or depression-like behavior can be found in rat strains with different susceptibility to audiogenic seizures (AS) and whether chronic fluoxetine treatment affects this co-morbidity." | 3.85 | Genetic background contributes to the co-morbidity of anxiety and depression with audiogenic seizure propensity and responses to fluoxetine treatment. ( Fedotova, IB; Kostina, ZA; Nikolaev, GM; Perepelkina, OV; Poletaeva, II; Sarkisova, KY; Surina, NM, 2017) |
| "The side effect profile and safety of fluoxetine are reviewed." | 3.75 | The side effect profile and safety of fluoxetine. ( Wernicke, JF, 1985) |
| " The present studies tested the possibility that the El mouse model of genetically predisposed/handling-triggered epilepsy would exhibit fewer seizures following SSRI treatment via dietary fluoxetine adulteration." | 3.74 | Seizure prophylaxis in an animal model of epilepsy by dietary fluoxetine supplementation. ( Heinrichs, SC; Richman, A, 2007) |
| "The aim of this study was to examine the effects of acute fluoxetine treatment on pentylenetetrazol-induced convulsions in order to shape a model of seizures associated with treatment with antidepressants in rats." | 3.73 | The effect of fluoxetine in a model of chemically induced seizures--behavioral and immunocytochemical study. ( Lehner, M; Maciejak, P; Płaźnik, A; Skórzewska, A; Taracha, E; Wisłowska, A; Zienowicz, M, 2005) |
| "This work was designed to study the influence of drugs during seizures and status epilepticus (SE) induced by pilocarpine and mortality in adult rats." | 3.73 | Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus. ( Fonteles, MM; Freitas, RM; Sousa, FC; Viana, GS, 2006) |
| "The effects of tianeptine and fluoxetine on pentylenetetrazole (PTZ)-induced seizures in rats were investigated." | 3.73 | Investigation of the effects of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats. ( Ceyhan, M; Kayir, H; Uzbay, IT, 2005) |
| " The present study was undertaken to examine the role of ALLO in the anticonvulsant action of fluoxetine against pentylenetetrazole (PTZ)-induced seizures in mice." | 3.72 | Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice. ( Chopde, CT; Hirani, K; Mittal, N; Ugale, RR, 2004) |
| " The present study assessed the effects of concomitant administration of fluoxetine and a 5-HT1A receptor antagonist, pindolol, on focal hippocampal (HIP) seizures elicited by electrical stimulation in rats." | 3.70 | Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats. ( Hirao, N; Koshino, Y; Nakamura, M; Shiraishi, J; Wada, Y, 1999) |
| "Previous case reports of seizures following fluoxetine overdose have not adequately ruled out ingestion of other substances and have lacked documentation of increased serum drug levels." | 3.69 | Seizure after isolated fluoxetine overdose. ( Braitberg, G; Curry, SC, 1995) |
| "The aim of our study was to analyse the possible implication of the serotoninergic system in the pathophysiology and the lethality of audiogenic seizures induced by magnesium deficiency, either by decreasing cerebral serotonin (5-HT) levels (p-chlorophenylalanine) or by increasing 5-HT levels in the brain (5-hydroxytryptophan, L-tryptophan, nialamide, fluoxetine)." | 3.69 | Effect of various serotoninergically induced manipulations on audiogenic seizures in magnesium-deficient mice. ( Bac, P; Binet, P; Dewulf, C; Durlach, J; Herrenknecht, C; Pages, N, 1994) |
| "Fluoxetine, a serotonin (5-HT) reuptake inhibitor, has been documented to exert a protective action against convulsive seizures in animal models, when administered either systemically, or focally into substantia nigra." | 3.69 | The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. ( Gale, K; Pasini, A; Tortorella, A, 1996) |
| "This study assessed the effects of acute as well as long-term administration of fluoxetine, a selective serotonin (5-HT) reuptake inhibitor with anti-depressant properties, on hippocampal (HIP) seizures elicited by electrical stimulation in rats." | 3.69 | Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. ( Hasegawa, H; Nakamura, M; Shiraishi, J; Wada, Y, 1995) |
| "0 nmol) into substantia nigra (SN) protected against convulsive seizures evoked by the focal injection of bicuculline methiodide into area tempestas, an epileptogenic site within the deep prepiriform cortex." | 3.68 | Anticonvulsant effect of intranigral fluoxetine. ( Gale, K; Pasini, A; Tortorella, A, 1992) |
| "Fluoxetine, an antidepressant and inhibitor of serotonin reuptake, was evaluated as an anticonvulsant in genetically epilepsy-prone rats (GEPRs) because seizure predisposition in GEPRs is partially dependent on deficits in brain serotonin." | 3.68 | Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. ( Burger, RL; Dailey, JW; Jobe, PC; Mishra, PK; Yan, QS, 1992) |
| "The effects of fluoxetine [an inhibitor of 5-hydroxytryptamine (5-HT) reuptake] on electrically-induced spinal cord seizures were determined by monitoring alterations in the total duration of seizure, as well as the durations of tonic flexion and extension." | 3.66 | Effects of fluoxetine on electrically-induced spinal cord seizures in rats. ( Jobe, PC; Ray, TB; Woods, TW, 1980) |
| "Nisoxetine and desipramine (inhibitors of norepinephrine reuptake) each exerted a suppressant effect on spinal cord seizures by decreasing the duration of tonic extension." | 3.66 | Effects of norepinephrine and 5-hydroxytryptamine reuptake inhibitors on electrically-induced spinal cord seizures in rats. ( Jobe, PC; Ray, TB, 1980) |
| "DBA mice exhibit seizure-induced respiratory arrest (S-IRA), leading to cardiac arrest and subsequent sudden death after generalized audiogenic seizures (AGSs)." | 2.55 | Abnormalities of serotonergic neurotransmission in animal models of SUDEP. ( Faingold, CL; Feng, HJ, 2017) |
| "Fluoxetine is a selective serotonin reuptake inhibitor that is less frequently associated with severe toxicity in acute overdose compared with other psychotropic medications." | 2.44 | Generalized seizures after acute fluoxetine overdose in four adolescents. ( Kolbeck, MK; Nacca, N; Schult, RF, 2024) |
| "Fluoxetine is a relatively new antidepressant, reported to have minimal side-effects." | 2.38 | Seizures associated with fluoxetine therapy. ( Prasher, VP, 1993) |
| "Complete freedom from seizures with cyanosis was reached in 3 (21 %) patients, and only one patient with early-onset epilepsy related to an FHF1 mutation was completely seizure-free." | 1.62 | Fluoxetine as adjunctive therapy in pediatric patients with refractory epilepsy: A retrospective analysis. ( Desnous, B; Milh, M; Neveu, J; Villeneuve, N, 2021) |
| "Audiogenic seizure-prone mice can be protected from seizure-associated death by exposure to an oxygen atmosphere or treatment with selective serotonergic reuptake inhibitors (SSRIs)." | 1.56 | An oxygen-rich atmosphere or systemic fluoxetine extend the time to respiratory arrest in a rat model of obstructive apnea. ( Banerjee, A; Gurevich, R; Kollmar, R; Mooney, S; Silverman, JB; Stewart, M; Sundaram, K; Tromblee, J, 2020) |
| "He had a generalised tonic/clonic seizure at 6 hours postingestion." | 1.48 | Fluoxetine overdose in a teenager resulting in serotonin syndrome, seizure and delayed onset rhabdomyolysis. ( Lee-Kelland, R; Mappa, P; Zehra, S, 2018) |
| "Treatment of Alzheimer's disease (AD) patients with the antidepressant fluoxetine is known to improve memory and cognitive function." | 1.43 | Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice. ( de Nijs, L; Hoogland, G; Prickaerts, J; Rutten, BP; Sierksma, AS; Steinbusch, HW; van den Hove, DL; van Leeuwen, FW; Vanmierlo, T, 2016) |
| "In the maximal electroshock seizure screen, compounds 5c and 5d showed moderate levels of anticonvulsant activity and protected 100% of the animals at a dose of 100 mg/kg." | 1.40 | Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones. ( Deng, XQ; Quan, ZS; Song, MX; Zheng, Y, 2014) |
| "Down syndrome is caused by triplication of chromosome 21 and is associated with neurocognitive phenotypes ranging from severe intellectual disability to various patterns of more selective neuropsychological deficits, including memory impairments." | 1.38 | Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome. ( Ehninger, D; Heinen, M; Hettich, MM; Paesler, K; Ryan, DP; Schnell, S, 2012) |
| "Stress can affect both depression and seizures." | 1.33 | Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice. ( Lazić, J; Pericić, D; Svob Strac, D, 2005) |
| "Serotonin syndrome is the result of the drug interaction that enhances serotonergic tone in the central nervous system." | 1.30 | Serotonin syndrome presenting with migrainelike stroke. ( Molaie, M, 1997) |
| "These seizures are characterized by running/bouncing clonus and tonic extensor convulsions." | 1.29 | Role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus ceruleus with DSP4. ( Bettendorf, AF; Browning, RA; Burger, RL; Jobe, PC; Mishra, PK, 1994) |
| "To report a syncopal episode associated with fluoxetine in a young, relatively healthy man." | 1.28 | Case report of a syncopal episode associated with fluoxetine. ( Dreyling, CA; McAnally, LE; Threlkeld, KR, 1992) |
| " In the present study we determined the time-course and dose-response effects of 6-MeO-THbetaC for blockade of AGS." | 1.26 | Effects of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (6-MeO-THbetaC) on audiogenic seizures in DBA/2J mice. ( Buckholtz, NS; Sparks, DL, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (11.90) | 18.7374 |
| 1990's | 27 (32.14) | 18.2507 |
| 2000's | 15 (17.86) | 29.6817 |
| 2010's | 21 (25.00) | 24.3611 |
| 2020's | 11 (13.10) | 2.80 |
| Authors | Studies |
|---|---|
| Rana, A | 1 |
| Siddiqui, N | 1 |
| Khan, SA | 1 |
| Ehtaishamul Haque, S | 1 |
| Bhat, MA | 1 |
| Wang, SB | 1 |
| Deng, XQ | 2 |
| Zheng, Y | 2 |
| Yuan, YP | 1 |
| Quan, ZS | 2 |
| Guan, LP | 2 |
| Song, MX | 1 |
| Neveu, J | 1 |
| Villeneuve, N | 1 |
| Milh, M | 1 |
| Desnous, B | 1 |
| Torun, IE | 1 |
| Kılınc, YB | 1 |
| Kilinc, E | 1 |
| Ambrosino, P | 1 |
| Ragona, F | 1 |
| Mosca, I | 1 |
| Vannicola, C | 1 |
| Canafoglia, L | 1 |
| Solazzi, R | 1 |
| Rivolta, I | 1 |
| Freri, E | 1 |
| Granata, T | 1 |
| Messina, G | 1 |
| Castellotti, B | 1 |
| Gellera, C | 1 |
| Soldovieri, MV | 1 |
| DiFrancesco, JC | 1 |
| Taglialatela, M | 1 |
| Rahati Quchani, M | 1 |
| Farmanesh, E | 1 |
| Esmaili, A | 1 |
| Moghimi, A | 1 |
| Fereidoni, M | 1 |
| Rahati Quchani, S | 1 |
| Campbell, S | 1 |
| Otten, H | 1 |
| Anand, V | 1 |
| Kolbeck, MK | 1 |
| Schult, RF | 1 |
| Nacca, N | 1 |
| Mooney, S | 1 |
| Kollmar, R | 1 |
| Gurevich, R | 1 |
| Tromblee, J | 1 |
| Banerjee, A | 1 |
| Sundaram, K | 1 |
| Silverman, JB | 1 |
| Stewart, M | 1 |
| Holanda, DKR | 1 |
| Wurlitzer, NJ | 1 |
| Dionisio, AP | 1 |
| Campos, AR | 1 |
| Moreira, RA | 1 |
| Sousa, PHM | 1 |
| Brito, ES | 1 |
| Ribeiro, PRV | 1 |
| Iunes, MF | 1 |
| Costa, AM | 1 |
| Pottoo, FH | 1 |
| Tabassum, N | 1 |
| Javed, MN | 1 |
| Nigar, S | 1 |
| Sharma, S | 1 |
| Barkat, MA | 1 |
| Alam, MS | 1 |
| Ansari, MA | 1 |
| Barreto, GE | 1 |
| Ashraf, GM | 1 |
| Christodoulos, IN | 1 |
| Chyou, TY | 1 |
| Nishtala, PS | 1 |
| Hankey, GJ | 1 |
| Hackett, ML | 1 |
| Almeida, OP | 1 |
| Flicker, L | 1 |
| Mead, GE | 1 |
| Dennis, MS | 1 |
| Etherton-Beer, C | 1 |
| Ford, AH | 1 |
| Billot, L | 1 |
| Jan, S | 1 |
| Lung, T | 1 |
| Lundström, E | 1 |
| Sunnerhagen, KS | 1 |
| Anderson, CS | 1 |
| Thang-Nguyen, H | 1 |
| Gommans, J | 1 |
| Yi, Q | 1 |
| Russell, JL | 1 |
| Spiller, HA | 1 |
| Chounthirath, T | 1 |
| Casavant, MJ | 1 |
| Querido, AL | 1 |
| Correia, P | 1 |
| Ribeiro, JA | 1 |
| Bento, C | 1 |
| Sales, F | 1 |
| Li, C | 1 |
| Silva, J | 1 |
| Ozturk, E | 1 |
| Dezsi, G | 1 |
| O'Brien, TJ | 1 |
| Renoir, T | 1 |
| Jones, NC | 1 |
| Lee-Kelland, R | 1 |
| Zehra, S | 1 |
| Mappa, P | 1 |
| Narasimha, VL | 1 |
| Basavaraju, R | 1 |
| Mangalore, S | 1 |
| Mehta, UM | 1 |
| Kruse, SW | 1 |
| Dayton, KG | 1 |
| Purnell, BS | 1 |
| Rosner, JI | 1 |
| Buchanan, GF | 1 |
| Jin, Q | 1 |
| Fu, Z | 1 |
| Guan, L | 1 |
| Jiang, H | 1 |
| Rodriguez-Osorio, X | 1 |
| Fernandez-Pajarin, G | 1 |
| Arias-Rivas, S | 1 |
| Requena-Caballero, I | 1 |
| Lopez-Gonzalez, FJ | 1 |
| Arias, M | 1 |
| Feng, HJ | 1 |
| Faingold, CL | 3 |
| Liu, BY | 1 |
| Quan, YC | 1 |
| Yang, LY | 1 |
| Zhen, XH | 1 |
| Wang, SH | 1 |
| Sierksma, AS | 1 |
| de Nijs, L | 1 |
| Hoogland, G | 1 |
| Vanmierlo, T | 1 |
| van Leeuwen, FW | 1 |
| Rutten, BP | 1 |
| Steinbusch, HW | 1 |
| Prickaerts, J | 1 |
| van den Hove, DL | 1 |
| Abouchedid, R | 1 |
| Ho, JH | 1 |
| Hudson, S | 1 |
| Dines, A | 1 |
| Archer, JR | 1 |
| Wood, DM | 1 |
| Dargan, PI | 1 |
| Sarkisova, KY | 1 |
| Fedotova, IB | 1 |
| Surina, NM | 1 |
| Nikolaev, GM | 1 |
| Perepelkina, OV | 1 |
| Kostina, ZA | 1 |
| Poletaeva, II | 1 |
| Temudo, T | 1 |
| Rios, M | 1 |
| Prior, C | 1 |
| Carrilho, I | 1 |
| Santos, M | 1 |
| Maciel, P | 1 |
| Sequeiros, J | 1 |
| Fonseca, M | 1 |
| Monteiro, J | 1 |
| Cabral, P | 1 |
| Vieira, JP | 1 |
| Ormazabal, A | 1 |
| Artuch, R | 1 |
| Tupal, S | 1 |
| Randall, M | 2 |
| Mhaskar, Y | 1 |
| Uteshev, VV | 1 |
| Igelström, KM | 1 |
| Heyward, PM | 1 |
| Heinen, M | 1 |
| Hettich, MM | 1 |
| Ryan, DP | 1 |
| Schnell, S | 1 |
| Paesler, K | 1 |
| Ehninger, D | 1 |
| Borowicz, KK | 2 |
| Piskorska, B | 1 |
| Stępniak, B | 1 |
| Czuczwar, SJ | 2 |
| Ugale, RR | 1 |
| Mittal, N | 1 |
| Hirani, K | 1 |
| Chopde, CT | 1 |
| Ceyhan, M | 1 |
| Kayir, H | 1 |
| Uzbay, IT | 1 |
| Zienowicz, M | 1 |
| Wisłowska, A | 1 |
| Lehner, M | 1 |
| Taracha, E | 1 |
| Skórzewska, A | 1 |
| Maciejak, P | 1 |
| Płaźnik, A | 1 |
| Pericić, D | 1 |
| Lazić, J | 1 |
| Svob Strac, D | 1 |
| Ferrero, AJ | 1 |
| Cereseto, M | 1 |
| Reinés, A | 1 |
| Bonavita, CD | 1 |
| Sifonios, LL | 1 |
| Rubio, MC | 1 |
| Wikinski, SI | 1 |
| Solberg, DK | 1 |
| Koht, J | 1 |
| Refsum, H | 1 |
| Freitas, RM | 1 |
| Sousa, FC | 1 |
| Viana, GS | 1 |
| Fonteles, MM | 1 |
| Richman, A | 1 |
| Heinrichs, SC | 1 |
| Furmanek-Karwowska, K | 1 |
| Sawicka, K | 1 |
| Luszczki, JJ | 1 |
| Jobe, PC | 5 |
| Woods, TW | 1 |
| Ray, TB | 2 |
| Sparks, DL | 1 |
| Buckholtz, NS | 1 |
| Wada, Y | 2 |
| Shiraishi, J | 2 |
| Nakamura, M | 2 |
| Hasegawa, H | 1 |
| Braitberg, G | 1 |
| Curry, SC | 1 |
| Sternbach, H | 1 |
| Tobiansky, RI | 1 |
| Lloyd, GG | 1 |
| Tobiansky, I | 1 |
| Lloyd, G | 1 |
| Nakielny, J | 1 |
| Bac, P | 1 |
| Pages, N | 1 |
| Herrenknecht, C | 1 |
| Dewulf, C | 1 |
| Binet, P | 1 |
| Durlach, J | 1 |
| Prasher, VP | 1 |
| Woods, DJ | 1 |
| Coulter, DM | 1 |
| Pillans, P | 1 |
| Mishra, PK | 2 |
| Burger, RL | 2 |
| Bettendorf, AF | 1 |
| Browning, RA | 2 |
| Gigli, GL | 1 |
| Diomedi, M | 1 |
| Troisi, A | 1 |
| Marciani, MG | 1 |
| Pasini, A | 3 |
| Walker, MC | 1 |
| Sander, JW | 1 |
| Tortorella, A | 2 |
| Gale, K | 2 |
| Statnick, M | 1 |
| Dailey, J | 1 |
| Jobe, P | 1 |
| Browning, R | 1 |
| Molaie, M | 1 |
| Jensen, K | 1 |
| Wood, AV | 1 |
| Merrill, MA | 1 |
| Dailey, JW | 2 |
| Lucena, MI | 1 |
| Blanco, E | 1 |
| Corrales, MA | 1 |
| Berthier, ML | 1 |
| Gross, R | 1 |
| Dannon, PN | 1 |
| Lepkifker, E | 1 |
| Zohar, J | 1 |
| Kotler, M | 1 |
| Raju, SS | 1 |
| Noor, AR | 1 |
| Gurthu, S | 1 |
| Giriyappanavar, CR | 1 |
| Acharya, SB | 1 |
| Low, HC | 1 |
| Quah, SH | 1 |
| Hirao, N | 1 |
| Koshino, Y | 1 |
| Epelde, F | 1 |
| Plà, R | 1 |
| Aguilar, M | 1 |
| Reus, VI | 1 |
| Rawitscher, L | 1 |
| Montero Pérez, FJ | 1 |
| Oke, A | 1 |
| Adhiyaman, V | 1 |
| Aziz, K | 1 |
| Ross, A | 1 |
| Sher, L | 1 |
| Siegel, J | 1 |
| Murphy, GJ | 1 |
| Bymaster, FB | 1 |
| Perry, KW | 1 |
| Fuller, RW | 1 |
| Wong, DT | 1 |
| Maj, J | 1 |
| Rogóz, Z | 1 |
| Skuza, G | 1 |
| Sowińska, H | 1 |
| McAnally, LE | 1 |
| Threlkeld, KR | 1 |
| Dreyling, CA | 1 |
| Hargrave, R | 1 |
| Martinez, D | 1 |
| Bernstein, AJ | 1 |
| Wroblewski, BA | 1 |
| Guidos, A | 1 |
| Leary, J | 1 |
| Joseph, AB | 1 |
| Yan, QS | 1 |
| Weber, JJ | 1 |
| Ware, MR | 1 |
| Stewart, RB | 1 |
| Golden, RN | 1 |
| Brown, TM | 1 |
| Miller, H | 1 |
| Evans, DL | 1 |
| Cooper, GL | 1 |
| Wernicke, JF | 1 |
7 reviews available for fluoxetine and Seizures
| Article | Year |
|---|---|
Diving and antidepressants.
Topics: Antidepressive Agents; Blood Glucose; Decompression Sickness; Diving; Fluoxetine; Hemorrhage; Humans | 2017 |
[Recurrence of encephalitis after 25 years due to anti-NMDA receptor antibodies].
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Autoantibodies; Autoantigens; Crit | 2014 |
Abnormalities of serotonergic neurotransmission in animal models of SUDEP.
Topics: Animals; Brain Stem; Death, Sudden; Disease Models, Animal; Epilepsy, Reflex; Fluoxetine; Humans; Ma | 2017 |
Seizures associated with fluoxetine therapy.
Topics: Adult; Depressive Disorder; Epilepsy, Tonic-Clonic; Female; Fluoxetine; Humans; Psychotic Disorders; | 1993 |
The new antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Fluoxetine; Maprotiline; Nomifensine; Seizures; Trazod | 1988 |
The safety of fluoxetine--an update.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Fluoxetine; Humans; Male | 1988 |
The side effect profile and safety of fluoxetine.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Clinical | 1985 |
4 trials available for fluoxetine and Seizures
| Article | Year |
|---|---|
Twelve-Month Outcomes of the AFFINITY Trial of Fluoxetine for Functional Recovery After Acute Stroke: AFFINITY Trial Steering Committee on Behalf of the AFFINITY Trial Collaboration.
Topics: Accidental Falls; Affect; Aged; Cognition; Double-Blind Method; Fatigue; Female; Fluoxetine; Fractur | 2021 |
Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment.
Topics: Administration, Oral; Child; Child, Preschool; DNA Mutational Analysis; Female; Fluoxetine; Folic Ac | 2009 |
Effects of fluoxetine on the anticonvulsant action of valproate and ethosuximide in mouse model of myoclonic convulsions.
Topics: Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Avoidance Learning; Convulsants; | 2012 |
The side effect profile and safety of fluoxetine.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Clinical | 1985 |
74 other studies available for fluoxetine and Seizures
| Article | Year |
|---|---|
N-{[(6-substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: synthesis and pharmacological evaluation.
Topics: Animals; Anticonvulsants; Benzamides; Benzothiazoles; Central Nervous System Depressants; Chemical a | 2008 |
Synthesis and evaluation of anticonvulsant and antidepressant activities of 5-alkoxytetrazolo[1,5-c]thieno[2,3-e]pyrimidine derivatives.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Male; Maze Learning; Mice; Mice, Inbred Strains; Mo | 2012 |
Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Behavior, Animal; Disease Models, Animal; Dose-Resp | 2014 |
Fluoxetine as adjunctive therapy in pediatric patients with refractory epilepsy: A retrospective analysis.
Topics: Adult; Anticonvulsants; Child; Drug Resistant Epilepsy; Epilepsy; Fluoxetine; Humans; Retrospective | 2021 |
Endogenous and exogenous serotonin, but not sumatriptan, ameliorate seizures and neuroinflammation in the pentylenetetrazole-induced seizure model in rats.
Topics: Animals; Anticonvulsants; Epilepsy; Fluoxetine; Humans; Interleukin-6; Male; Neuroinflammatory Disea | 2022 |
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine.
Topics: Animals; Cricetinae; Cricetulus; Epilepsies, Myoclonic; Fluoxetine; Gain of Function Mutation; Preci | 2023 |
Behavioral and electrophysiological (ECoG) effects of haplophyllum robustum and TRPA1 antagonist in adult male wistar rats.
Topics: Animals; Diazepam; Fluoxetine; Plant Extracts; Rats; Rats, Wistar; Rutaceae; Seizures | 2023 |
CYP450 Genetic Polymorphisms: Generalized Tonic-Clonic Seizure after Intentional Fluoxetine and Melatonin Overdose.
Topics: Cytochrome P-450 Enzyme System; Drug Overdose; Drug-Related Side Effects and Adverse Reactions; Fluo | 2023 |
Generalized seizures after acute fluoxetine overdose in four adolescents.
Topics: Adolescent; Child; Drug Overdose; Fluoxetine; Humans; Seizures; Selective Serotonin Reuptake Inhibit | 2024 |
An oxygen-rich atmosphere or systemic fluoxetine extend the time to respiratory arrest in a rat model of obstructive apnea.
Topics: Animals; Death, Sudden; Fluoxetine; Male; Oxygen; Rats, Sprague-Dawley; Respiration; Seizures; Selec | 2020 |
Garlic passion fruit (Passiflora tenuifila Killip): Assessment of eventual acute toxicity, anxiolytic, sedative, and anticonvulsant effects using in vivo assays.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Anxiety; Behavior, Animal; Dia | 2020 |
Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice.
Topics: Animals; Anticonvulsants; Bromocriptine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combi | 2020 |
Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Second-Generation; Anxie | 2020 |
Pediatric ingestion of vilazodone compared to other selective serotonin reuptake inhibitor medications.
Topics: Child; Child, Preschool; Citalopram; Coma; Dose-Response Relationship, Drug; Evidence-Based Medicine | 2017 |
Negative myoclonus secondary to paroxetine intake.
Topics: Aged; Electroencephalography; Fluoxetine; Humans; Male; Medical Errors; Myoclonus; Paroxetine; Seizu | 2018 |
Chronic fluoxetine treatment accelerates kindling epileptogenesis in mice independently of 5-HT
Topics: Amygdala; Animals; Fluoxetine; Genotype; Homozygote; Kindling, Neurologic; Long-Term Care; Male; Mic | 2018 |
Fluoxetine overdose in a teenager resulting in serotonin syndrome, seizure and delayed onset rhabdomyolysis.
Topics: Adolescent; Depressive Disorder; Diagnosis, Differential; Drug Overdose; Fluoxetine; Humans; Male; R | 2018 |
Precuneus and psychiatric manifestations: Novel neurobiological formulations through lesion based connectivity mapping of psychopathology.
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain Mapping; Brai | 2019 |
Effect of monoamine reuptake inhibition and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochl | 2019 |
Syntheses of Benzo[
Topics: Animals; Antarctic Regions; Anticonvulsants; Antidepressive Agents; Aquatic Organisms; Benzothiazole | 2019 |
Synthesis and Evaluation of Phenyliminoindolin-Containing Phenylacetamide Derivatives with the Antidepressant and Anticonvulsant Effects.
Topics: Acetanilides; Animals; Anticonvulsants; Antidepressive Agents; Dopamine; Electroshock; Fluoxetine; H | 2016 |
Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anticonvulsants; Body Weight; Disease Mo | 2016 |
Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.
Topics: Adamantane; Administration, Intravenous; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Citalop | 2016 |
Genetic background contributes to the co-morbidity of anxiety and depression with audiogenic seizure propensity and responses to fluoxetine treatment.
Topics: Animals; Antidepressive Agents; Anxiety; Depression; Disease Models, Animal; Epilepsy, Reflex; Fluox | 2017 |
Prevention of seizure-induced sudden death in a chronic SUDEP model by semichronic administration of a selective serotonin reuptake inhibitor.
Topics: Acoustic Stimulation; Animals; Chi-Square Distribution; Death, Sudden; Death, Sudden, Cardiac; Disea | 2011 |
Differences in serotonin receptor expression in the brainstem may explain the differential ability of a serotonin agonist to block seizure-induced sudden death in DBA/2 vs. DBA/1 mice.
Topics: Animals; Brain Stem; Death, Sudden; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxe | 2011 |
The antidepressant drug fluoxetine inhibits persistent sodium currents and seizure-like events.
Topics: Action Potentials; Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Dose-Response | 2012 |
Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome.
Topics: Animals; Behavior, Animal; Body Weight; Cell Count; Cognition Disorders; Down Syndrome; Female; Fluo | 2012 |
Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; gamma-Aminob | 2004 |
Investigation of the effects of tianeptine and fluoxetine on pentylenetetrazole-induced seizures in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Convulsants; Fe | 2005 |
The effect of fluoxetine in a model of chemically induced seizures--behavioral and immunocytochemical study.
Topics: Animals; Drug Interactions; Drug Synergism; Fluoxetine; Hippocampus; Immunohistochemistry; Male; Pen | 2005 |
Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Disease M | 2005 |
Chronic treatment with fluoxetine decreases seizure threshold in naïve but not in rats exposed to the learned helplessness paradigm: Correlation with the hippocampal glutamate release.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Convulsants; Dizocilpine Maleat | 2005 |
[A 74-year-old unconscious woman with myoclonia and seizures].
Topics: Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Citalopram; F | 2006 |
Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus.
Topics: Amines; Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tri | 2006 |
Seizure prophylaxis in an animal model of epilepsy by dietary fluoxetine supplementation.
Topics: Animal Feed; Animals; Anticonvulsants; Disease Models, Animal; Drug Administration Schedule; Fluoxet | 2007 |
Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.
Topics: Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Drug Interactions; Drug Synergis | 2007 |
Effects of fluoxetine on electrically-induced spinal cord seizures in rats.
Topics: Animals; Electric Stimulation; Female; Fluoxetine; Hydroxyindoleacetic Acid; Propylamines; Rats; Sei | 1980 |
Effects of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (6-MeO-THbetaC) on audiogenic seizures in DBA/2J mice.
Topics: 5-Hydroxytryptophan; Acoustic Stimulation; Animals; Benzofurans; Carbolines; Citalopram; Clomipramin | 1980 |
Effects of norepinephrine and 5-hydroxytryptamine reuptake inhibitors on electrically-induced spinal cord seizures in rats.
Topics: Animals; Benzofurans; Citalopram; Desipramine; Electric Stimulation; Female; Fluoxetine; Norepinephr | 1980 |
Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats.
Topics: Animals; Anticonvulsants; Electric Stimulation; Fluoxetine; Hippocampus; Injections, Intraperitoneal | 1995 |
Seizure after isolated fluoxetine overdose.
Topics: Adolescent; Chromatography, High Pressure Liquid; Drug Overdose; Female; Fluoxetine; Humans; Seizure | 1995 |
Fluoxetine-clomipramine interaction.
Topics: Adult; Clomipramine; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Fem | 1995 |
ECT seizure threshold and fluoxetine.
Topics: Amitriptyline; Combined Modality Therapy; Depressive Disorder; Drug Therapy, Combination; Electrocon | 1995 |
Seizures and antidepressants.
Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Fluoxetine; Humans; Risk Factors; Seizure | 1994 |
Effect of various serotoninergically induced manipulations on audiogenic seizures in magnesium-deficient mice.
Topics: 5-Hydroxytryptophan; Acoustic Stimulation; Analysis of Variance; Animals; Brain; Fenclonine; Fluoxet | 1994 |
Interaction of phenytoin and fluoxetine.
Topics: Contraindications; Drug Interactions; Female; Fluoxetine; Humans; Middle Aged; Phenytoin; Seizures | 1994 |
Role of norepinephrine in forebrain and brainstem seizures: chemical lesioning of locus ceruleus with DSP4.
Topics: Animals; Benzylamines; Brain Stem; Differential Threshold; Dose-Response Relationship, Drug; Female; | 1994 |
Fluoxetine and seizures.
Topics: Fluoxetine; Humans; Seizures | 1996 |
Fluoxetine and seizures.
Topics: Fluoxetine; Humans; Seizures | 1996 |
The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anticonvulsants; Bicuculline; Convulsants; Fencloni | 1996 |
Neither intranigral fluoxetine nor 5,7-dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats.
Topics: 5,7-Dihydroxytryptamine; Acoustic Stimulation; Animals; Biogenic Monoamines; Fluoxetine; Injections, | 1996 |
Serotonin syndrome presenting with migrainelike stroke.
Topics: Adult; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Clomipramine; Confusi | 1997 |
[Adverse Effects Tribunal--convulsions due to treatment with selective serotonin uptake inhibitors].
Topics: Adult; Aged; Antidepressive Agents; Female; Fluoxetine; Humans; Male; Middle Aged; Seizures; Selecti | 1997 |
Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Brain; Cyclohexylamines; Drug Interactions; Female; | 1997 |
Interaction of fluoxetine and valproic acid.
Topics: Adult; Comorbidity; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Female; | 1998 |
Generalized seizures caused by fluoxetine overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Drug Overdose; Fluoxetine; Humans; Male; Seizures; | 1998 |
Effect of fluoxetine on maximal electroshock seizures in mice: acute vs chronic administration.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroshock; Fluoxetine; Male; Mice; Mi | 1999 |
Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats.
Topics: Animals; Drug Synergism; Fluoxetine; Hippocampus; Male; Pindolol; Rats; Rats, Wistar; Receptors, Ser | 1999 |
[Seizures crisis following sudden stop of fluoxetine].
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Administration Schedule; | 1999 |
Possible interaction of tramadol and antidepressants.
Topics: Antidepressive Agents; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Obs | 2000 |
[Fluoxetine and convulsive crisis].
Topics: Antidepressive Agents, Second-Generation; Fluoxetine; Humans; Seizures; Selective Serotonin Reuptake | 2000 |
Dose-dependent seizure activity associated with fluoxetine therapy.
Topics: Depression; Female; Fluoxetine; Humans; Middle Aged; Seizures; Selective Serotonin Reuptake Inhibito | 2001 |
Antidepressants and side-effects.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Fluoxetine; Humans; Seizures | 2001 |
Serotonergic inhibition of amygdala-kindled seizures in cats.
Topics: Amygdala; Animals; Cats; Electric Stimulation; Evoked Potentials; Fluoxetine; Neural Inhibition; p-C | 1979 |
Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsions.
Topics: Animals; Brain Stem; Cerebral Cortex; Decerebrate State; Desipramine; Dose-Response Relationship, Dr | 1977 |
The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
Topics: Animals; Antidepressive Agents; Benzazepines; Citalopram; Dizocilpine Maleate; Fluoxetine; Imipramin | 1992 |
Case report of a syncopal episode associated with fluoxetine.
Topics: Adult; Electrocardiography; Electroencephalography; Fluoxetine; Humans; Male; Neurologic Examination | 1992 |
Anticonvulsant effect of intranigral fluoxetine.
Topics: Animals; Anticonvulsants; Bicuculline; Cerebral Cortex; Convulsants; Fluoxetine; Male; Microinjectio | 1992 |
Fluoxetine-induced seizures.
Topics: Adult; Depressive Disorder; Epilepsy, Tonic-Clonic; Female; Fluoxetine; Humans; Male; Middle Aged; S | 1992 |
Control of depression with fluoxetine and antiseizure medication in a brain-injured patient.
Topics: Adult; Brain Injuries; Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Male; Phe | 1992 |
Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
Topics: Animals; Brain; Dialysis; Epilepsy; Female; Fluoxetine; Male; Rats; Seizures; Serotonin; Thalamus | 1992 |
Seizure activity associated with fluoxetine therapy.
Topics: Aged; Aged, 80 and over; Electroencephalography; Female; Fluoxetine; Humans; Salicylates; Seizures | 1989 |
Seizures associated with fluoxetine therapy.
Topics: Adult; Female; Fluoxetine; Humans; Seizures | 1989 |